CeriBell, Inc.(CBLL) - 2025 Q1 - Quarterly Results

Ceribell Reports First Quarter 2025 Financial Results SUNNYVALE, Calif., May 8, 2025 – CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended March 31, 2025. First Quarter 2025 & Recent Highlights Cash, cash equivalents, and marketable securities totaled $182.7 million as of March 31, 2025. 2025 Financial Outlook Ceribell is raising i ...